Good MorningThe S&P 500 pulled back on Tuesday as market participants braced for Wednesday's FOMC interest rate decision. The committee is not expected to cut rates at this meeting, but may indicate a cut in an upcoming one. The risk for the markets is that uncertainty in the outlook could keep the FOMC from acting, and, even if they do, forces out of their control drive macroeconomic conditions in 2025. A recession may be unavoidable.
Where the market goes next may already be determined. The trade environment is not improving, and tariffs still stand. S&P 500 companies are cutting or suspending guidance, and the forecast for 2025 earnings growth is deteriorating. In this scenario, the market has nowhere to go but down and could set new lows before summer. The caution for investors and traders is that positive news regarding trade could be announced at any time and reinvigorate the bull market. Featured: Sell these "safe" blue chips immediately (Ad) 
|
Technology | |
Trading near its 52-week low around $20, Intel (NASDAQ: INTC) presents a seemingly inexpensive investment in the semiconductor sector as we near the middle of 2025. This low valuation, however, clashes with Intel’s analyst community’s cautious consensus rating and a weak financial outl... Read the Full Story |
|
From Our Partners | | Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. | | Watch the full story and see the verified track record for yourself |
|
Healthcare | |
While major market indexes like the S&P 500 have struggled to gain traction in 2025 and remain in the red YTD, certain pockets of the market are showing impressive strength. Several medical and biotechnology sector mid-cap stocks have stood out for their resilience and outperformance. Investor... Read the Full Story |
|
Healthcare | |
Insiders are buying stock in 2025, and activity is not limited to a single sector or market cap. This article looks at the top three insider buys from April based on market cap and the number of insiders buying.
The number of insiders buying is a more critical metric than dollar value or shares b... Read the Full Story |
|
From Our Partners | | Moderna's stock doubled in a single day after its cancer vaccine hit key Phase 3 goals, and Merck jumped too. But according to a former Steve Cohen fund manager, the next big opportunity is not Moderna or Merck.
It is a different kind of company tied to a technology already backed by Elon Musk, Sam Altman, Jeff Bezos, and Peter Thiel. Nvidia's Jensen Huang says it will have a dramatic impact on daily life, while Anthropic's CEO believes it could unlock a century of medical progress in just ten years.
Nature Magazine estimates its potential value at $367 trillion globally, and it is already rolling out across the United States. | | Click here to learn about this new era of medical technology |
|
Healthcare | |
The world’s largest pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), recently had its worst day in a long, long time. On May 1, Lilly reported Q1 earnings. Afterwards, shares got beaten down by almost 12% in one day, marking the biggest single-day decline in the stock in recent mem... Read the Full Story |
|
Healthcare | |
There are only a few companies that come around every half-decade or so that really get the gears turning in terms of having the right fundamental makeup for value investors. It just so happens that these companies (when caught early on) are too small to even be on the radar of the bigger sharks i... Read the Full Story |
|
From Our Partners | | Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. | | Discover the gold income fund before the next payout date |
|
Technology | |
Microsoft Corporation (NASDAQ: MSFT) announced that prices for its popular Xbox gaming console will increase due to rising development costs associated with tariffs. The news, while logical, shows that technology stocks aren't completely insulated from the current tariff problems besetting the b... Read the Full Story |
|
Markets | |
Whether focusing on growth stocks, value stocks, or a mix, the goal is the same: find and invest in undervalued assets. This thread remains true when considering how to invest across the 11 different stock market sectors. At certain times, specific sectors can see their value relative to the overa... Read the Full Story |
|
Consumer Staples | |
After greatly underperforming the S&P 500 Index in 2023 and 2024, the consumer staples sector is punching back this year. As of the May 2 close, the S&P 500 Index had provided a total return of approximately -3% in 2025. Conversely, the Consumer Staples Select Sector SPDR Fund (NYSEARCA: X... Read the Full Story |
|
Technology | |
It would be hard to blame investors for being excited about the Palantir Technologies Inc. (NASDAQ: PLTR) earnings report. The stock has been the best-performing stock in 2025, delivering a return of over 60% since January.
However, after a strong earnings report in which the company beat on ... Read the Full Story |
|
Technology | |
D-Wave Quantum Inc. (NYSE: QBTS) is among the most talked-about firms in a heavily hyped industry. Quantum computing companies, D-Wave plus rivals like Rigetti Computing Inc. (NASDAQ: RGTI) and legacy computing firm International Business Machines (NYSE: IBM), could usher in a new way for humans... Read the Full Story |
|
Wednesday's Early Bird Stock Of The Day Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 6,700 customers principally across two major categories: business-to-business and retail/online fulfillment. | Should I Buy Prologis Stock? PLD Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Prologis was last updated on Sunday, August 30, 2026 at 6:18 PM.
Prologis Bull Case -
The current stock price is around $142, which is near its 50-day moving average, indicating stability in recent trading.
-
Prologis, Inc. reported strong earnings, with earnings per share surpassing estimates significantly, showcasing robust financial performance.
-
The company has a solid market capitalization of approximately $132.49 billion, reflecting its strong position in the real estate investment trust sector.
-
Analysts have a consensus rating of "Moderate Buy" for Prologis, Inc., with a price target suggesting potential for growth.
-
Prologis, Inc. has demonstrated a year-over-year revenue increase of 11%, indicating strong demand for its logistics and distribution facilities.
Prologis Bear Case -
The company has a quick ratio and current ratio of 0.70, which may indicate potential liquidity concerns in meeting short-term obligations.
-
Prologis, Inc. experienced a decline in earnings per share compared to the previous year, which could signal challenges in maintaining profitability.
-
The debt-to-equity ratio of 0.63 suggests that the company is somewhat leveraged, which could pose risks in a rising interest rate environment.
-
Market volatility, as indicated by a beta of 1.31, suggests that Prologis, Inc. may experience larger price fluctuations compared to the overall market.
-
Recent analyst price targets vary significantly, indicating uncertainty about the stock's future performance and potential for price swings.
| | View Today's Stock Pick |
|
